Lisbon, Portugal – At the LSX World Congress Europe in Lisbon, Per Norlén, CEO of Strike Pharma, joined leaders from across the life sciences sector, including biotechnology and medtech companies, investors, healthcare organisations, and R&D leaders.

The event provided an opportunity to engage in discussions around innovation and emerging developments within the industry, while also connecting with partners, collaborators, and stakeholders across the global life sciences community. Strike Pharma values the opportunity to share its vision and ongoing work in next-generation therapeutic development.